J Bone Metab.  2014 Nov;21(4):263-268. 10.11005/jbm.2014.21.4.263.

Undertreatment of Osteoporosis Following Hip Fractures in Jeju Cohort Study

• Kim SR
• Park YG
• Kang SY
• Nam KW
• Park YG
• Ha YC

• KMID: 2170054
• DOI: http://doi.org/10.11005/jbm.2014.21.4.263

Abstract

BACKGROUND
Osteoporosis treatment following hip fracture is well known to not enough. We previously performed intervention study for orthopaedic surgeon's education and reported twofold increase in osteoporosis detection and treatment rate observed between 2005 and 2007. This follow-up observational study was conducted to find out the rate in which a diagnostic workup and treatment for osteoporosis were done in patients with hip fracture.
METHODS
Medical records and radiographs in patients who were older than 50 years and diagnosed as having femoral neck or intertrochanteric fractures at 8 hospitals in Jeju island, South Korea from 2008 to 2011 were reviewed. The numbers of patients who were studied with bone densitometry and who were treated for osteoporosis after the diagnosis of hip fracture were analyzed.
RESULTS
Nine hundred forty five hip fractures (201 in 2008, 257 in 2009, 265 in 2010, and 304 in 2011) occurred in 191 men and 754 women during the study periods. The mean age of the patients was 79.7 years. The mean rate of osteoporosis detection using dual energy X-ray absorptiometry was 36.4% (344/945 hips) (ranged from 24.2% in 2009 to 40.5% in 2011). The mean initiation rate of osteoporosis treatment was 23.1% (218/945 hips) (ranged from 20% in 2009 to 29% in 2008).
CONCLUSIONS
Detection and treatment rate of osteoporosis following hip fracture during follow-up periods was still not enough. Additional intervention studies are required to further improvement of osteoporosis treatment rates after hip fracture.

Keyword

Bone density conservation agents; Hip fractures; Osteoporosis; Therapeutics

MeSH Terms

Absorptiometry, Photon
Bone Density Conservation Agents
Cohort Studies*
Clinical Trial
Densitometry
Diagnosis
Education
Female
Femur Neck
Follow-Up Studies
Hip
Hip Fractures*
Humans
Korea
Male
Medical Records
Observational Study
Osteoporosis*
Bone Density Conservation Agents

Reference

1. Shin CS, Choi HJ, Kim MJ, et al. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone. 2010; 47:378–387.

2. Choi YJ, Oh HJ, Kim DJ, et al. The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008-2009. J Bone Miner Res. 2012; 27:1879–1886.

3. Choi HJ, Shin CS, Ha YC, et al. Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab. 2012; 30:54–58.

4. Park C, Ha YC, Jang S, et al. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. 2011; 29:744–751.

5. Lee YK, Lee YJ, Ha YC, et al. Five-year relative survival of patients with osteoporotic hip fracture. J Clin Endocrinol Metab. 2014; 99:97–100.

6. Yoon HK, Park C, Jang S, et al. Incidence and mortality following hip fracture in Korea. J Korean Med Sci. 2011; 26:1087–1092.

7. Juby AG, De Geus-Wenceslau CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int. 2002; 13:205–210.

8. Kang BJ, Lee YK, Lee KW, et al. Mortality after hip fractures in nonagenarians. J Bone Metab. 2012; 19:83–86.

9. Lee SR, Ha YC, Kang H, et al. Morbidity and mortality in Jeju residents over 50-years of age with hip fracture with mean 6-year follow-up: a prospective cohort study. J Korean Med Sci. 2013; 28:1089–1094.

10. Tsuboi M, Hasegawa Y, Suzuki S, et al. Mortality and mobility after hip fracture in Japan: a ten-year follow-up. J Bone Joint Surg Br. 2007; 89:461–466.

11. Borgquist L, Ceder L, Thorngren KG. Function and social status 10 years after hip fracture. Prospective follow-up of 103 patients. Acta Orthop Scand. 1990; 61:404–410.

12. Black DM, Reid IR, Boonen S, et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2012; 27:243–254.

13. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet. 2002; 359:2018–2026.

14. Hochberg MC, Thompson DE, Black DM, et al. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res. 2005; 20:971–976.

15. Mithal A, Kaur P. Osteoporosis in Asia: a call to action. Curr Osteoporos Rep. 2012; 10:245–247.

16. Varthakavi PK, Joshi AS, Bhagwat NM, et al. Osteoporosis treatment in India: call for action. Indian J Endocrinol Metab. 2014; 18:441–442.

17. Lai MM, Ang WM, McGuiness M, et al. Undertreatment of osteoporosis in regional Western Australia. Australas J Ageing. 2012; 31:110–114.

18. Kim SR, Ha YC, Park YG, et al. Orthopedic surgeon's awareness can improve osteoporosis treatment following hip fracture: a prospective cohort study. J Korean Med Sci. 2011; 26:1501–1507.

19. Kim SR, Ha YC, Kim JR, et al. Incidence of hip fractures in Jeju Island, South Korea: a prospective study (2002-2006). Clin Orthop Surg. 2010; 2:64–68.

20. Johnell K, Fastbom J. Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos. 2009; 4:17–23.

21. Shibli-Rahhal A, Vaughan-Sarrazin MS, Richardson K, et al. Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system. Osteoporos Int. 2011; 22:2973–2980.

22. Curtis JR, McClure LA, Delzell E, et al. Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med. 2009; 24:956–962.

23. Harrington JT, Broy SB, Derosa AM, et al. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum. 2002; 47:651–654.

24. Siris ES, Bilezikian JP, Rubin MR, et al. Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab. 2003; 88:3482–3486.

25. Yi H, Ha YC, Lee YK, et al. National healthcare budget impact analysis of the treatment for osteoporosis and fractures in Korea. J Bone Metab. 2013; 20:17–23.

26. Goeree R, Blackhouse G, Adachi J. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Curr Med Res Opin. 2006; 22:1425–1436.

27. Lee YK, Ha YC, Yoon BH, et al. Incidence of second hip fracture and compliant use of bisphosphonate. Osteoporos Int. 2013; 24:2099–2104.

28. Lee YK, Ha YC, Choi HJ, et al. Bisphosphonate use and subsequent hip fracture in South Korea. Osteoporos Int. 2013; 24:2887–2892.

29. Lyles KW, Colón-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007; 357:1799–1809.

30. Miki RA, Oetgen ME, Kirk J, et al. Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial. J Bone Joint Surg Am. 2008; 90:2346–2353.

31. Cranney A, Lam M, Ruhland L, et al. A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int. 2008; 19:1733–1740.

32. Majumdar SR, Beaupre LA, Harley CH, et al. Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med. 2007; 167:2110–2115.

33. Rowe SM, Yoon TR, Ryang DH. An epidemiological study of hip fracture in Honam, Korea. Int Orthop. 1993; 17:139–143.

34. Mannius S, Mellström D, Odén A, et al. Incidence of hip fracture in western Sweden 1974-1982. Comparison of rural and urban populations. Acta Orthop Scand. 1987; 58:38–42.

35. Solbakken SM, Magnus JH, Meyer HE, et al. Impact of comorbidity, age, and gender on seasonal variation in hip fracture incidence. A NOREPOS study. Arch Osteoporos. 2014; 9:191.

36. Rális ZA. Epidemic of fractures during period of snow and ice. Br Med J (Clin Res Ed). 1981; 282:603–605.

37. Chiu KY, Ng TP, Chow SP. Seasonal variation of fractures of the hip in elderly persons. Injury. 1996; 27:333–336.

38. Levy AR, Bensimon DR, Mayo NE, et al. Inclement weather and the risk of hip fracture. Epidemiology. 1998; 9:172–177.

39. Ha YC, Lee YK, Lim YT, et al. Physicians' attitudes to contemporary issues on osteoporosis management in Korea. J Bone Metab. 2014; 21:143–149.